Assessing health-related quality of life: application to drug therapy
- PMID: 1286494
Assessing health-related quality of life: application to drug therapy
Abstract
There is growing awareness among the principal stakeholders in health care that health outcomes data should be used in the evaluation of medical care interventions. Health-related quality of life is a patient-reported health outcome that is gaining increasing attention. In fact, in certain diseases, quality of life may be the most important health outcome to consider in assessing treatment efficacy. Quality of life is a construct commonly viewed as having several dimensions or domains. Although the terminology may differ depending on the author, the basic dimensions of health-related quality of life are physical status and functioning, emotional/psychological status, social functioning, and disease- or treatment-related symptomatology. There are a number of methodologic issues in the measurement of quality of life that must be carefully considered when designing a study or evaluating existing research. These issues include general or disease-specific measures, index or profile outcome measures, dimensions measured, relative importance of dimensions, reliability of the measure, and validity of the measure. This paper provides a brief overview of health-related quality of life and its measurement in the context of drug therapy.
Similar articles
-
Quality of life assessment: understanding its use as an outcome measure.Hosp Formul. 1993 May;28(5):486-90, 492, 497-8. Hosp Formul. 1993. PMID: 10125806
-
Defining and assessing health-related quality of life.Cent Eur J Public Health. 1999 Nov;7(4):207-9. Cent Eur J Public Health. 1999. PMID: 10659384
-
Quality of life measurement in mental health. Introduction and overview of workshop findings.Can J Commun Ment Health. 1998 Winter;(3 Suppl):9-20, 9-21. Can J Commun Ment Health. 1998. PMID: 10344890 English, French.
-
Overview of health-related quality-of-life measures.Am J Hosp Pharm. 1992 Sep;49(9):2236-45. Am J Hosp Pharm. 1992. PMID: 1524070 Review.
-
Critical evaluation of the use of research tools in evaluating quality of life for people with schizophrenia.Int J Ment Health Nurs. 2007 Feb;16(1):2-14. doi: 10.1111/j.1447-0349.2006.00438.x. Int J Ment Health Nurs. 2007. PMID: 17229269 Review.
Cited by
-
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).Health Qual Life Outcomes. 2003 Nov 21;1:69. doi: 10.1186/1477-7525-1-69. Health Qual Life Outcomes. 2003. PMID: 14633279 Free PMC article.
-
Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.J Natl Compr Canc Netw. 2011 Mar;9(3):268-78. doi: 10.6004/jnccn.2011.0026. J Natl Compr Canc Netw. 2011. PMID: 21393439 Free PMC article.
-
The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus.Qual Life Res. 1997 Jan;6(1):11-20. doi: 10.1023/a:1026487509852. Qual Life Res. 1997. PMID: 9062437
-
Patient-reported outcomes as end points and outcome indicators in solid tumours.Nat Rev Clin Oncol. 2015 Jun;12(6):358-70. doi: 10.1038/nrclinonc.2015.29. Epub 2015 Mar 10. Nat Rev Clin Oncol. 2015. PMID: 25754949 Review.
-
Translating safety, efficacy and compliance into economic value for controlled release dosage forms.Pharmacoeconomics. 1994 Jun;5(6):482-504. doi: 10.2165/00019053-199405060-00005. Pharmacoeconomics. 1994. PMID: 10150160
MeSH terms
LinkOut - more resources
Other Literature Sources